Roundtable Discussion: Acute Stroke Intervention - BCIS (ACI 2017)
Published: 28 February 2018
-
Views:
79
-
Likes:
7
-
Views:
79
-
Likes:
7
-
Part 1 SESSION 1: DATA & LITERATURE REVIEW Adrian P Banning, Iqbal Malik, Helen Routledge, Andrew SP Sharp, Marcus Bradley
-
Part 2 NEED SESSION 2 TITLE & VIDEO Adrian P Banning
Overview
During the British Cardiovascular Intervention Society (BCIS) "Advanced Cardiovascular Intervention (ACI 2018)" meeting in London (24-26th January 2017), Radcliffe Cardiology filmed a roundtable discussion focusing on an area of growing interest amongst the interventional community – Acute Stroke Intervention.
This discussion was moderated by BCIS President Prof. Adrian Banning (Oxford, UK) who was joined by an expert group of physicians including Dr. Marcus Bradley (Bristol, UK), Dr. Iqbal Malik (London,UK), Dr. Helen Routledge (Worcester, UK) and Dr. Andrew Sharp (Exeter, UK).
Learning objective
- To consider whether there is a role for ICs in acute stroke intervention
- To review the literature on acute stroke intervention
- To discuss best practice treatment strategy for ACIs
- To discuss how ICs should approach acute stroke interventions
- To debate the best path forward for these patients
Panellists
- Adrian Banning - John Radcliffe Hospital, Oxford, UK
- Marcus Bradley - North Bristol NHS Trust, Bristol, UK
- Iqbal Malik - Imperial College London, London, UK
- Helen Routledge - NHS Worcester Acute Hospitals, Worcester, UK
- Andrew Sharp - Royal Devon and Exeter Hospital, Exeter, UK
More from this programme
Part 1
SESSION 1: DATA & LITERATURE REVIEW
| 1 session | |
| SESSION 1: DATA & LITERATURE REVIEW | Watch now |
Part 2
NEED SESSION 2 TITLE & VIDEO
| 1 session | |
| NEED SESSION 2 TITLE & VIDEO | Watch now |
Part 3
SESSION 3: IS THERE A ROLE FOR CARDIOLOGISTS IN TREATING ACUTE STROKE AND HOW SHOULD THEY DO IT?
Faculty Biographies
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.